Literature DB >> 1415522

Plasma GSH/GSSG affects glucose homeostasis in healthy subjects and non-insulin-dependent diabetics.

G Paolisso1, G Di Maro, G Pizza, A D'Amore, S Sgambato, P Tesauro, M Varricchio, F D'Onofrio.   

Abstract

In healthy subjects (n = 10) and non-insulin-dependent (type II) diabetics (n = 10) matched for age [43.1 +/- 2.2 vs. 41 +/- 4.4 yr, P = not significant (NS)], body mass index (25.1 +/- 1.1 vs. 26 +/- 0.8 kg/m2, P = NS), gender ratio [5 males (M)/5 females (F) vs. 5M/5F], and mean arterial blood pressure (105 +/- 7 vs. 106 +/- 9 mmHg, P = NS), we determined the changes in insulin secretion and action after glutathione infusion (15 mg/min) and the relative increase in the plasma reduced (GSH)/oxidized (GSSG) glutathione ratio. The rise in the plasma GSH/GSSG ratio significantly improved total body glucose disposal in healthy subjects and in diabetic patients. In this latter group, GSH infusion potentiated the beta-cell response to glucose slightly. In controls and diabetics, insulin infusion with a simultaneous increase in the plasma GSH/GSSG ratio significantly enhanced nonoxidative glucose disposal without affecting oxidative glucose metabolism. After glutathione infusion, all metabolic and hormonal changes correlated with a significant decline in plasma membrane microviscosity. In conclusion, the plasma GSH/GSSG ratio seems to play a major role in the modulation of glucose homeostasis mainly in diabetics.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1415522     DOI: 10.1152/ajpendo.1992.263.3.E435

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  22 in total

1.  Dietary vitamin E and C supplementation prevents fructose induced hypertension in rats.

Authors:  S Vasdev; V Gill; S Parai; L Longerich; V Gadag
Journal:  Mol Cell Biochem       Date:  2002-12       Impact factor: 3.396

Review 2.  Oxidative stress and insulin action: is there a relationship?

Authors:  G Paolisso; D Giugliano
Journal:  Diabetologia       Date:  1996-03       Impact factor: 10.122

Review 3.  Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus.

Authors:  Surapon Tangvarasittichai
Journal:  World J Diabetes       Date:  2015-04-15

4.  S-allylcysteine Improves Streptozotocin-Induced Alterations of Blood Glucose, Liver Cytochrome P450 2E1, Plasma Antioxidant System, and Adipocytes Hormones in Diabetic Rats.

Authors:  Ganapathy Saravanan; Ponnusamy Ponmurugan
Journal:  Int J Endocrinol Metab       Date:  2013-10-01

5.  Low-dose Iloprost infusion improves insulin action and non-oxidative glucose metabolism in hypertensive patients.

Authors:  G Paolisso; A Gambardella; F Saccomanno; G Varricchio; A D'Amore; M Varricchio
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

6.  Mitochondrial reactive oxygen species generation in obese non-diabetic and type 2 diabetic participants.

Authors:  M A Abdul-Ghani; R Jani; A Chavez; M Molina-Carrion; D Tripathy; R A Defronzo
Journal:  Diabetologia       Date:  2009-01-30       Impact factor: 10.122

7.  The erythrocyte glutathione levels during oral glucose tolerance test.

Authors:  D Konukoğlu; H Hatemi; E M Ozer; S Gönen; T Akçay
Journal:  J Endocrinol Invest       Date:  1997-09       Impact factor: 4.256

8.  The effect of glutathione treatment on the biochemical and immunohistochemical profile in streptozotocin-induced diabetic rats.

Authors:  Fatmagül Yur; Semiha Dede; Turan Karaca; Sevim Ciftçi Yegin; Yeter Değer; Hülya Ozdemir
Journal:  J Membr Biol       Date:  2013-05-17       Impact factor: 1.843

9.  Opposite effects of short- and long-term fatty acid infusion on insulin secretion in healthy subjects.

Authors:  G Paolisso; A Gambardella; L Amato; R Tortoriello; A D'Amore; M Varricchio; F D'Onofrio
Journal:  Diabetologia       Date:  1995-11       Impact factor: 10.122

10.  Co-administration of glutathione and nitric oxide enhances insulin sensitivity in Wistar rats.

Authors:  Maria P Guarino; M Paula Macedo
Journal:  Br J Pharmacol       Date:  2006-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.